EBV BART miRNAs: Identification of Targets and Characterization of the Effects o

EBV BART miRNA:目标鉴定和效应表征

基本信息

项目摘要

DESCRIPTION (provided by applicant): The human tumor virus, Epstein Barr Virus (EBV), encodes multiple microRNAs (miRNAs) that are expressed during latent infection in tumors. Two groups of miRNAs have been identified. One group is only expressed in transformed lymphocytes in Type III latency. The second group containing two clusters is produced from a complex family of transcripts, termed BARTs, from the BamHI A region of the genome. Importantly, these transcripts are highly produced in EBV-associated tumors but are expressed at low levels in infected B-lymphoid cell lines. Several of the EBV miRNAS are highly conserved with those identified in rhesus EBV with considerably greater homology than EBV/KSHV coding sequences. This conservation of sequences suggests that the miRNAs might target cellular messages. Based on these findings, this application will test the hypothesis that the EBV BART miRNAs target cellular genes to affect growth regulation. The proposed experiments will use a combination of bioinformatic, microarray, and proteomics to identify the cellular targets of the BART miRNAs. Cell lines that stably express the BART miRNAs will be produced to confirm expression and to determine the effects of the miRNAs on cellular growth properties. Multiple cellular signaling pathways are affected by EBV transforming proteins so potential modulation of these pathways by the BART miRNAs will also be examined. The effects of loss of miRNA expression in EBV infected cells will be assessed using antagomirs, sponges, and inhibitors of miRNA synthesis. Cellular miRNAs have been shown to be major factors in the development of cancer. This proposal will determine how the EBV miRNAs contribute to EBV-mediated oncogenesis. PUBLIC HEALTH RELEVANCE: Infection with Epstein-Barr virus contributes to the development of several important human malignancies through the effects of viral proteins on cell growth regulation. A new form of growth regulation has been discovered that involves small RNAs (miRNAs) that affect the function of cellular genes and contribute to cancer. EBV encodes multiple miRNAs that we have shown to be expressed at high levels in some EBV-associated cancers particularly nasopharyngeal carcinoma. The identification of cellular proteins that are targeted by the EBV miRNAs will increase our understanding of how EBV contributes to the development of cancer.
描述(由申请人提供):人类肿瘤病毒,EB病毒(EBV),编码多种微RNA(miRNA),这些微RNA(miRNA)在肿瘤潜伏感染期间表达。已鉴定出两组 miRNA。一组仅在 III 型潜伏期的转化淋巴细胞中表达。第二组包含两个簇,由来自基因组 BamHI A 区域的复杂转录本家族(称为 BART)产生。重要的是,这些转录本在 EBV 相关肿瘤中大量产生,但在受感染的 B 淋巴细胞系中表达水平较低。一些 EBV miRNA 与恒河猴 EBV 中鉴定的 miRNA 高度保守,与 EBV/KSHV 编码序列具有显着更高的同源性。这种序列的保守性表明 miRNA 可能以细胞信息为目标。基于这些发现,该应用将测试 EBV BART miRNA 靶向细胞基因以影响生长调节的假设。拟议的实验将结合生物信息学、微阵列和蛋白质组学来识别 BART miRNA 的细胞靶标。将产生稳定表达 BART miRNA 的细胞系,以确认表达并确定 miRNA 对细胞生长特性的影响。多种细胞信号传导途径受到 EBV 转化蛋白的影响,因此还将检查 BART miRNA 对这些途径的潜在调节。将使用 antagomir、海绵和 miRNA 合成抑制剂来评估 EBV 感染细胞中 miRNA 表达丧失的影响。细胞 miRNA 已被证明是癌症发展的主要因素。该提案将确定 EBV miRNA 如何促进 EBV 介导的肿瘤发生。 公共卫生相关性:EB 病毒感染通过病毒蛋白对细胞生长调节的影响,导致多种重要的人类恶性肿瘤的发生。人们发现了一种新的生长调节形式,它涉及影响细胞基因功能并导致癌症的小 RNA (miRNA)。 EBV 编码多种 miRNA,我们已证明这些 miRNA 在一些 EBV 相关癌症(尤其是鼻咽癌)中高水平表达。 EBV miRNA 靶向的细胞蛋白的鉴定将加深我们对 EBV 如何促进癌症发展的理解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NANCY JOAN RAAB-TRAUB其他文献

NANCY JOAN RAAB-TRAUB的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NANCY JOAN RAAB-TRAUB', 18)}}的其他基金

Virology
病毒学
  • 批准号:
    8340212
  • 财政年份:
    2011
  • 资助金额:
    $ 29.66万
  • 项目类别:
Virology
病毒学
  • 批准号:
    8340213
  • 财政年份:
    2011
  • 资助金额:
    $ 29.66万
  • 项目类别:
EBV BART miRNAs: Identification of Targets and Characterization of the Effects o
EBV BART miRNA:目标鉴定和效应表征
  • 批准号:
    8386652
  • 财政年份:
    2009
  • 资助金额:
    $ 29.66万
  • 项目类别:
EBV BART miRNAs: Identification of Targets and Characterization of the Effects o
EBV BART miRNA:目标鉴定和效应表征
  • 批准号:
    7785008
  • 财政年份:
    2009
  • 资助金额:
    $ 29.66万
  • 项目类别:
EBV BART miRNAs: Identification of Targets and Characterization of the Effects o
EBV BART miRNA:目标鉴定和效应表征
  • 批准号:
    8585832
  • 财政年份:
    2009
  • 资助金额:
    $ 29.66万
  • 项目类别:
EBV BART miRNAs: Identification of Targets and Characterization of the Effects o
EBV BART miRNA:目标鉴定和效应表征
  • 批准号:
    7995263
  • 财政年份:
    2009
  • 资助金额:
    $ 29.66万
  • 项目类别:
Herpesviral Oncogenesis, Latency and Reactivation
疱疹病毒肿瘤发生、潜伏期和再激活
  • 批准号:
    7908032
  • 财政年份:
    2009
  • 资助金额:
    $ 29.66万
  • 项目类别:
ADMINISTRATION CORE
管理核心
  • 批准号:
    6930192
  • 财政年份:
    2005
  • 资助金额:
    $ 29.66万
  • 项目类别:
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEINS 1 AND 2
EBV 潜伏膜蛋白 1 和 2 的转化
  • 批准号:
    6930190
  • 财政年份:
    2005
  • 资助金额:
    $ 29.66万
  • 项目类别:
Epstein-Barr Virus: Activation of WNT
Epstein-Barr 病毒:WNT 激活
  • 批准号:
    7105558
  • 财政年份:
    2004
  • 资助金额:
    $ 29.66万
  • 项目类别:

相似海外基金

Impact of alternative polyadenylation of 3'-untranslated regions in the PI3K/AKT cascade on microRNA
PI3K/AKT 级联中 3-非翻译区的替代多聚腺苷酸化对 microRNA 的影响
  • 批准号:
    573541-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 29.66万
  • 项目类别:
    University Undergraduate Student Research Awards
How do untranslated regions of cannabinoid receptor type 1 mRNA determine receptor subcellular localisation and function?
1 型大麻素受体 mRNA 的非翻译区如何决定受体亚细胞定位和功能?
  • 批准号:
    2744317
  • 财政年份:
    2022
  • 资助金额:
    $ 29.66万
  • 项目类别:
    Studentship
MICA:Synthetic untranslated regions for direct delivery of therapeutic mRNAs
MICA:用于直接递送治疗性 mRNA 的合成非翻译区
  • 批准号:
    MR/V010948/1
  • 财政年份:
    2021
  • 资助金额:
    $ 29.66万
  • 项目类别:
    Research Grant
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
  • 批准号:
    10019570
  • 财政年份:
    2019
  • 资助金额:
    $ 29.66万
  • 项目类别:
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
  • 批准号:
    10223370
  • 财政年份:
    2019
  • 资助金额:
    $ 29.66万
  • 项目类别:
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
  • 批准号:
    10455108
  • 财政年份:
    2019
  • 资助金额:
    $ 29.66万
  • 项目类别:
Synergistic microRNA-binding sites, and 3' untranslated regions: a dialogue of silence
协同的 microRNA 结合位点和 3 非翻译区:沉默的对话
  • 批准号:
    255762
  • 财政年份:
    2012
  • 资助金额:
    $ 29.66万
  • 项目类别:
    Operating Grants
Analysis of long untranslated regions in Nipah virus genome
尼帕病毒基因组长非翻译区分析
  • 批准号:
    20790351
  • 财政年份:
    2008
  • 资助金额:
    $ 29.66万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Search for mRNA elements involved in the compatibility between 5' untranslated regions and coding regions in chloroplast translation
寻找参与叶绿体翻译中 5 非翻译区和编码区之间兼容性的 mRNA 元件
  • 批准号:
    19370021
  • 财政年份:
    2007
  • 资助金额:
    $ 29.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Post-transcriptional Regulation of PPAR-g Expression by 5'-Untranslated Regions
5-非翻译区对 PPAR-g 表达的转录后调控
  • 批准号:
    7131841
  • 财政年份:
    2006
  • 资助金额:
    $ 29.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了